| Product Code: ETC13140103 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America mRNA Vaccine and Therapeutics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America mRNA Vaccine and Therapeutics Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 North America mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 North America mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 North America mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 North America mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 North America mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 North America mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 North America mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America mRNA Vaccine and Therapeutics Market Trends |
6 North America mRNA Vaccine and Therapeutics Market, 2021 - 2031 |
6.1 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021 - 2031 |
6.1.3 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021 - 2031 |
6.2 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Cancer, 2021 - 2031 |
6.2.3 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.2.4 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Autoimmune Diseases, 2021 - 2031 |
6.2.5 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Other, 2021 - 2031 |
6.3 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Monoclonal Antibody, 2021 - 2031 |
6.3.3 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Gene Therapy, 2021 - 2031 |
6.3.4 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Cell Therapy, 2021 - 2031 |
6.3.5 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Other, 2021 - 2031 |
6.4 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031 |
6.4.2 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Research Laboratories and Organizations, 2021 - 2031 |
6.4.3 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.4 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.5 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America mRNA Vaccine and Therapeutics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.1 United States (US) mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.2 Canada mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.3 Rest of North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3 North America mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United States (US) mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Canada mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Rest of North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.1 United States (US) mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.2 Canada mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.3 Rest of North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5 North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031 |
7.5.1 United States (US) mRNA Vaccine and Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031 |
7.5.2 Canada mRNA Vaccine and Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031 |
7.5.3 Rest of North America mRNA Vaccine and Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031 |
8 North America mRNA Vaccine and Therapeutics Market Key Performance Indicators |
9 North America mRNA Vaccine and Therapeutics Market - Export/Import By Countries Assessment |
10 North America mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
10.1 North America mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.3 North America mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 North America mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10.5 North America mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
11 North America mRNA Vaccine and Therapeutics Market - Competitive Landscape |
11.1 North America mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2022 |
11.2 North America mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here